Skip to main content

Site notifications

Notice for belzutifan (Merck Sharp & Dohme (Australia) Pty Ltd)

Active ingredients
belzutifan
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology

Help us improve this page